Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Отворен

1.8 12.5

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.56

Максимум

1.83

Ключови измерители
By Trading Economics
Приходи	1.6M -2.9M
Марж на печалбата	-2,954
Служители	21

Дивиденти
By Acuity
Следващи печалби	5.11.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	5.3M 12M
Предишно отваряне	-10.7
Предишно затваряне	1.8

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.09.2026 г., 23:51 ч. UTC

Australia's Consumer Confidence Index set for release amid mixed market sentiment and rising interest rate concerns.

7.09.2026 г., 23:51 ч. UTC

Australia's Westpac Consumer Confidence Index set for release on September 8, amid cautious optimism in the stock market despite global economic uncertainties.

7.09.2026 г., 23:51 ч. UTC

UK Retail Sales Growth Slows to 0.5% YoY, Falling Short of Expectations Amid Consumer Caution

7.09.2026 г., 23:51 ч. UTC

U.S. Initial Jobless Claims Expected at 205,000 Amid Strong Labor Market and Anticipated Fed Rate Hikes

7.09.2026 г., 23:51 ч. UTC

China's Producer Prices Index Expected to Rise 3.7% Amid Mixed Economic Signals Ahead of September Release

7.09.2026 г., 23:41 ч. UTC

Japan's Q2 2026 GDP Growth Rate Expected at 0.4% Amid Optimistic Economic Sentiment and Rising Nikkei Index

7.09.2026 г., 23:41 ч. UTC

Japan's Q2 2026 GDP Growth Expected at +1.1% Amid Positive Economic Trends and Optimistic Market Sentiment

7.09.2026 г., 23:41 ч. UTC

Japan's Current Account Expected at JPY 2,870 Billion Amid Positive Economic Sentiment and Speculation of Interest Rate Hikes.

7.09.2026 г., 23:31 ч. UTC

ECB President Lagarde's Upcoming Speech Sparks Market Anticipation for Rate Hike Amid Rising Inflation and Geopolitical Tensions.

7.09.2026 г., 23:21 ч. UTC

U.S. Core Inflation Rate Expected to Rise to 2.4% YoY Amid Strong Jobs Data, Heightening Speculation on Fed Interest Rate Hikes

7.09.2026 г., 23:21 ч. UTC

Core Inflation Rate Release on September 11, 2026, Expected to Influence Fed's Interest Rate Decisions Amid Rising Geopolitical Tensions and Oil Prices.

7.09.2026 г., 23:21 ч. UTC

Investors Brace for CPI Release Amid Rising Inflation Concerns and Fed Rate Hike Speculation on September 11, 2026.

7.09.2026 г., 23:21 ч. UTC

U.S. Inflation Rate Expected to Rise 0.4% in August Amid Concerns of Federal Reserve Interest Rate Hikes Following Strong Job Growth

7.09.2026 г., 23:21 ч. UTC

U.S. CPI Report on September 11, 2026 Expected to Show Inflation Rise Amid Market Caution and Fed Rate Hike Speculation

7.09.2026 г., 23:21 ч. UTC

U.S. Inflation Rate Expected to Rise 3.4% YoY, Heightening Fed Rate Hike Speculations Amid Geopolitical Tensions and Oil Price Surge

7.09.2026 г., 23:11 ч. UTC

U.S. Core Producer Prices Expected to Rise 0.3% in August Amid Geopolitical Tensions and Inflation Concerns

7.09.2026 г., 23:01 ч. UTC

U.S. Producer Price Inflation (PPI) MoM for August set to release on September 10, with a forecasted rise of 0.4% amid inflation concerns and potential Fed interest rate hikes due to geopolitical tensions affecting oil prices.

7.09.2026 г., 23:01 ч. UTC

NZD/JPY is lower today amid broader market volatility and geopolitical tensions following U.S. military actions against Iranian tankers. The pair remains near its one-month low.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

AUD/JPY is trading lower, continuing a decline since Friday's close amid geopolitical tensions affecting investor sentiment and energy supply concerns.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

GBP/JPY is declining amid heightened market volatility from geopolitical tensions and U.S. military actions, continuing lower since Friday's close.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

CAD/JPY is declining, continuing a downward trend since Friday's close, influenced by geopolitical tensions and market volatility. The pair trades below its 20-day moving average.

7.09.2026 г., 23:01 ч. UTC

Macro News

The USD/JPY currency pair is trading lower as the yen strengthens amid global economic uncertainties and tensions in the Middle East.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

The EUR/JPY is lower today amid rising geopolitical tensions and a drop in USD/JPY. The exchange rate remains below its 20-day moving average.

7.09.2026 г., 23:01 ч. UTC

Correlated Moves

CHF/JPY is trading lower as geopolitical tensions influence market sentiment, following a notable decline earlier in the session. The pair remains below its 20-day moving average.

7.09.2026 г., 22:51 ч. UTC

Markets Anticipate ECB Deposit Facility Rate Hike Amid Rising Inflation and Geopolitical Tensions Ahead of September 10 Meeting.

7.09.2026 г., 22:21 ч. UTC

India's Inflation Rate Release on September 14, 2026, Sparks Caution Amid Geopolitical Tensions and Rising Costs.

7.09.2026 г., 22:11 ч. UTC

Mexico's Inflation Rate YoY for August 2026 set to release on September 9, with a forecast of 3.30% amid rising global oil prices and geopolitical tensions.

7.09.2026 г., 22:11 ч. UTC

Mexico's Inflation Rate Expected to Rise 0.25% in August Amid Global Economic Pressures and U.S. Interest Rate Concerns.

7.09.2026 г., 22:01 ч. UTC

MBA 30-Year Mortgage Rate Release on September 9, Amid Rising Rates and Anticipated Fed Hikes Influenced by Inflation Concerns.

7.09.2026 г., 21:51 ч. UTC

Brazil's Central Bank to Announce Interest Rate Decision Amid Global Economic Uncertainty on September 8, 2026.

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Печалба преди облагане с данъци

Продажби

Оперативна печалба

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.